Improved superovulatory response in beef cattle following ovarian follicular ablation using a simplified transvaginal device.
The influence of the timing for the ablation of dominant follicle(s) prior to superovulatory treatment, and its effect on ovarian follicular growth and embryo yield, still remain elusive in cattle. The present study was designed to evaluate the effects of: (1) the day of the estrous cycle, at mid-diestrus, for the onset of superstimulation of follicular development, (2) the presence or absence of large ovarian follicles (ovary status) and (3) the time of follicular ablation, in hours, prior to the superovulatory treatment, on the superovulatory response in cattle. From a total of 244 superovulatory treatments and embryo collections in nulliparous and multiparous females, 76 were conducted after follicular ablation using a simplified transvaginal puncture cannula. Results from the present study indicated that the presence of large palpable follicle(s) at the onset of superstimulation of follicular development markedly reduced the superovulatory response. In addition, follicular ablation at 0 h or at 24 h prior to the onset of the superstimulation treatment significantly increased the number of total viable embryos. However, superovulatory responses were not affected by the day of the estrous cycle for the onset of follicular superstimulation and by the animal category (heifers or cows). In conclusion, the ablation of palpable follicle(s) 24 h or immediately prior to the onset of gonadotropin treatment, from days 8 to 12 of the estrous cycle (day 0, behavioral estrus), increased the total number of transferable embryos per flushing in cattle.
Lima
W M
WM
Universidade Federal do Rio Grande do Sul, Faculdade de Veterinária, FAVET/UFRGS, Porto Alegre, RS 91501-970, Brazil. wagner.marques@terra.com.br
Vieira
A D
AD
Thaller Neto
A
A
Mezzalira
A
A
Matos
R C
RC
Gregory
R M
RM
D000818:Animals; D002417:Cattle / Q000502:physiology*; D003008:Cloprostenol / Q000494:pharmacology; D005260:Female; D005640:Follicle Stimulating Hormone / Q000494:pharmacology; D006080:Ovarian Follicle / Q000502:physiology*; D013480:Superovulation / Q000187:drug effects / Q000502:physiology*; D013997:Time Factors; D014621:Vagina
D003008:Cloprostenol; D005640:Follicle Stimulating Hormone